Soluble factors from human endometrium promote angiogenesis and regulate the endothelial cell transcriptome
Human endometrial supernatants, particularly from the proliferative phase, contain soluble factors including VEGF-A that promote endothelial cell proliferation, angiogenesis, and alter the endothelial transcriptome.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (63)
- Antiangiogenic agents are effective inhibitors of endometriosis via openalex
- Cell proliferation is increased in the endometrium of women with endometriosis via openalex
- Concentration of soluble intercellular adhesion molecule-1 in serum samples from patients with endometriosis collected during the luteal phase of the menstrual cycle via openalex
- Differential regulation of matrix metalloproteinase-3 gene expression in endometriotic lesions compared with endometrium via openalex
- Endometrial vascular and glandular expression of integrin alpha(v)beta3 in women with and without endometriosis via openalex
- Etiology and histogenesis of endometriosis via openalex
- Expression of the vascular endothelial growth factors B and C and their receptors in human endometrium during the menstrual cycle via openalex
- Expression profiling of endometrium from women with endometriosis reveals candidate genes for disease-based implantation failure and infertility via openalex
- Extracellular matrix remodelling in the endometrium and its possible relevance to the pathogenesis of endometriosis via openalex
- Immunoexpression of hepatocyte growth factor and c-Met receptor in the eutopic endometrium predicts the activity of ectopic endometrium via openalex
- Immunohistochemical localization of acidic and basic fibroblast growth factors in normal human endometrium and endometriosis and the detection of their mRNA by polymerase chain reaction via openalex
- Increased expression of endoglin in the eutopic endometrium of women with endometriosis via openalex
- In-vivo angiogenesis and progestogens via openalex
- Marked elevation of macrophage migration inhibitory factor in the peritoneal fluid of women with endometriosis via openalex
- Nitric oxide synthesis is increased in the endometrial tissue of women with endometriosis via openalex
- Serum concentrations of insulin-like growth factor-1, soluble tumor necrosis factor receptor-1 and angiogenin in endometriosis patients via openalex
- Survivin gene expression in endometriosis via openalex
- Tumor necrosis factor alpha secretion by peritoneal macrophages in patients with endometriosis via openalex
- Vascular endothelial growth factor expression in human endometrium is regulated by hypoxia via openalex
- Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids via openalex
- Women with endometriosis have increased levels of placental growth factor in the peritoneal fluid compared with women with cystadenomas via openalex
- W2132883779 via openalex
- W2136428504 via openalex
- W2136699192 via openalex
- W2140246703 via openalex
- W2144210999 via openalex
- W2145068950 via openalex
- W2147496720 via openalex
- W2152750025 via openalex
- W2154785421 via openalex
- W2157603347 via openalex
- W2160535102 via openalex
- W2160882660 via openalex
- W2165621847 via openalex
- W2171500397 via openalex
- W2187963245 via openalex
- W4229618597 via openalex
- W4234539374 via openalex
- W4244785215 via openalex
- W4248561355 via openalex
- W4250428608 via openalex
- W1600721209 via openalex
- W4252981482 via openalex
- W1970762272 via openalex
- W1972068610 via openalex
- W1974462266 via openalex
- W2001525526 via openalex
- W2013631219 via openalex
- W2017556192 via openalex
- W2034024594 via openalex
- W2040827803 via openalex
- W2051109788 via openalex
- W2052546763 via openalex
- W2060479127 via openalex
- W2065081355 via openalex
- W2079474508 via openalex
- W2086619383 via openalex
- W2105518293 via openalex
- W2106487610 via openalex
- W2111654463 via openalex
- W2125338361 via openalex
- W2127368795 via openalex
- W2128930486 via openalex
Cited by (13)
- The Role of the Microenvironment in Endometriosis: Parallels and Distinctions to Cancer 2022
- Development of peritoneal endometriosis: Characterisation of immune environment in peritoneal endometriotic lesions 2015
- Identification of local angiogenic and inflammatory markers in the menstrual blood of women with endometriosis 2014
- Comparative evaluation of vascular endothelial growth factor-A expression in pre-ovulatory follicular fluid in normogonadotrophic and endometriotic patients undergoing assisted reproductive techniques 2013
- Expression of vascular endothelial growth factor (VEGF) and its soluble receptor-1 in endometriosis 2012
- Pelvic Mechanisms Involved in the Pathophysiology of Pain in Endometriosis 2011
- Angiogenesis and Endometriosis 2011
- Microanatomy and function of the eutopic endometrium in women with endometriosis 2008
- Metalloproteinases, vascular endothelial growth factor, and angiopoietin 1 and 2 in eutopic and ectopic endometrium 2008
- Promotion of angiogenesis by human endometrial lymphocytes 2008
- Polymorphisms in the vascular endothelial growth factor gene and the risk of familial endometriosis 2008
- Menstrual effluent in endometriosis shows no difference in volume, VEGF-A, MMP2 and MMP9 or sFLT 2006
- Vascular development in endometriosis 2005
Source provenance
- europepmc
- last seen: 2026-10-14T06:08:39.101224+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T21:02:35.474120+00:00